Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : THE WHITE HOUSE -- Ignore unavailable to you. Want to Upgrade?

To: Gersh Avery who wrote (21957)	9/8/2008 2:28:31 PM
From: DuckTapeSunroof	Read Replies (1) \| Respond to of 25737

FYI - For you Gersh: medical researchers link THC to anti-bacterial effectiveness, particularly against methicillin-resistant Staphylococcus aureus, or MRSA September 9, 2008 Observatory: Marijuana Ingredient May Fight Bacteria By HENRY FOUNTAIN nytimes.com Marijuana may be something of a wonder drug — though perhaps not in the way you might think. Researchers in Italy and Britain have found that the main active ingredient in marijuana — tetrahydrocannabinol, or THC — and related compounds show promise as antibacterial agents, particularly against microbial strains that are already resistant to several classes of drugs. It has been known for decades that Cannabis sativa has antibacterial properties. Experiments in the 1950s tested various marijuana preparations against skin and other infections, but researchers at the time had little understanding of marijuana’s chemical makeup. The current research, by Giovanni Appendino of the University of the Eastern Piedmont and colleagues and published in The Journal of Natural Products, looked at the antibacterial activity of the five most common cannabinoids. All were found effective against several common multi-resistant bacterial strains, although, perhaps understandably, the researchers suggested that the nonpsychotropic cannabinoids might prove more promising for eventual use. The researchers say they don’t know how the cannabinoids work, and whether they would be effective as systemic antibiotics would require much more research and trials. But the compounds may prove useful sooner as a topical agent against methicillin-resistant Staphylococcus aureus, or MRSA, to prevent the microbes from colonizing on the skin. Copyright 2008 The New York Times Company